Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-244262
Filing Date
2010-11-02
Accepted
2010-11-02 15:45:35
Documents
10
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 643119
2 CERTIFICATION BY LEONARD BELL, CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 9621
3 CERTIFICATION BY VIKAS SINHA, SR. VICE PRESIDENT & CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 9676
4 CERTIFICATION BY LEONARD BELL, CFO PURSUANT TO SECTION 906 dex321.htm EX-32.1 4326
5 CERTIFICATION BY VIKAS SINHA, SR. VICE PRESIDENT & CFO PURSUANT TO SECTION 906 dex322.htm EX-32.2 4408
  Complete submission text file 0001193125-10-244262.txt   2279685

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alxn-20100930.xml EX-101.INS 252115
7 XBRL TAXONOMY EXTENSION SCHEMA alxn-20100930.xsd EX-101.SCH 12733
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alxn-20100930_cal.xml EX-101.CAL 35987
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxn-20100930_lab.xml EX-101.LAB 114866
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxn-20100930_pre.xml EX-101.PRE 76916
Mailing Address 352 KNOTTER DRIVE CHESHIRE CT 06511
Business Address 352 KNOTTER DRIVE CHESHIRE CT 06511 2037761790
ALEXION PHARMACEUTICALS INC (Filer) CIK: 0000899866 (see all company filings)

EIN.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27756 | Film No.: 101158199
SIC: 2834 Pharmaceutical Preparations